$LLY Trade Levels (Weekly)Entry Zone (Demand): $680 – $700
Stop-Loss: Below $660 (invalidates demand zone)
First Target (Resistance): $800 – $820
Second Target (Supply): $880 – $920
R/R Setup: ~1:3 if entry at demand and target at upper supply
Key facts today
300 ARS
9.70 T ARS
41.24 T ARS
About Eli Lilly and Company
Sector
Industry
CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
ISIN
ARDEUT111192
FIGI
BBG000HFTQS8
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Related stocks
Eli Lilly (LLY) Weekly Chart – Double Top Patterns & Major SuppoLLY has formed consecutive double top patterns within a broad descending channel.
Price recently tested a long-term major support zone and bounced strongly, signaling renewed buying interest. If this momentum holds, a move toward the major resistance near $973 is possible, aligning with the upper
$LLY: Decision Zone — Wedge Breakout or Retest of 685Eli Lilly (LLY) rebounded off the long-term trendline and weekly demand box (≈622–686) and is compressing inside a descending wedge.
Bullish path (blue): a clean break and retest of wedge resistance opens room toward the prior extension/marker near ~970.
Bearish path (red): rejection at the
Lilly Has Fallen. Can it Get Up?Eli Lilly has been trending lower, and some traders may see further downside risk in the pharma giant.
The first pattern on today’s chart is the bearish gap on August 7. The decline came despite better-than-expected quarterly results, which may reflect weakening fundamentals.
Second is the May 23
Still in Mark-Down stageBelow the 200 DMA and the VWAP anchored to the stage 2 mark-up start. I don't think we're at the accumulation stage yet. Not even close.
LLY - Clean Levels UpdatedEli Lilly's hit those 708.49 and 711 levels I mentioned in my previous LLY post.
I've added some weekly levels, and a couple relevant spots from my boxed LLY chart.
If LLY loses steam up here we could easily see a retest of that box top area in the $680 - $678 range. Otherwise if we see a market
LLY eyes on $635.82: Major fib may hold earnings + news CRASHLLY earnings plus some GLP news tanked the stock.
But the crash came to an abrupt halt at a Genesis fib.
Look for a bounce but expect bears at the Golden's above.
LLY $720 Call Setup: Don’t Miss Out on This Breakout Play!🚀 LLY Weekly Options Analysis (2025-08-17) 🚀
### 🔎 Comprehensive Multi-Model Insights
**Grok/xAI Report**
* 📊 RSI: Neutral (Daily & Weekly \~46)
* 📈 Flow: Call/Put = **3.87 (Bullish bias)**
* 🔊 Volume: Weak vs. previous weeks → ⚠️ no strong institutional support
* 🛑 Trade: **No entry** (weak conf
LLY AUG-2025Eli Lilly ( NYSE:LLY ) rebounded strongly from the 640 support zone after institutional absorption. Price is now targeting the gap at 740, aligning with prior distribution levels. Sustained momentum above 700 could drive continuation into 737–740. Failure to hold above 640 risks a deeper move into t
Red Pill or Blue Pill?Red Pill first - let’s stick to some harsh realities, but using technical analysis only.
Why the harsh crash?
We were rejected at the Value Area high at $972, followed by another rejection at the 0.786 Fibonacci level at $916, along with the top of the flag pattern of this giant bull flag. This wa
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
LLY.GV
Eli Lilly and Company 5.5% 15-MAR-2027Yield to maturity
—
Maturity date
Mar 15, 2027
LLY6153505
Eli Lilly and Company FRN 15-OCT-2028Yield to maturity
—
Maturity date
Oct 15, 2028
LLY6003480
Eli Lilly and Company 4.55% 12-FEB-2028Yield to maturity
—
Maturity date
Feb 12, 2028
LLY6003481
Eli Lilly and Company 4.75% 12-FEB-2030Yield to maturity
—
Maturity date
Feb 12, 2030
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044Yield to maturity
—
Maturity date
Jun 15, 2044
LLY6003092
Eli Lilly and Company 5.1% 12-FEB-2035Yield to maturity
—
Maturity date
Feb 12, 2035
LLY5871803
Eli Lilly and Company 5.05% 14-AUG-2054Yield to maturity
—
Maturity date
Aug 14, 2054
LLY6003397
Eli Lilly and Company 5.6% 12-FEB-2065Yield to maturity
—
Maturity date
Feb 12, 2065
LLY6153504
Eli Lilly and Company 4.55% 15-OCT-2032Yield to maturity
—
Maturity date
Oct 15, 2032
LLY.HW
Eli Lilly and Company 5.95% 15-NOV-2037Yield to maturity
—
Maturity date
Nov 15, 2037
LLY5871809
Eli Lilly and Company 4.15% 14-AUG-2027Yield to maturity
—
Maturity date
Aug 14, 2027
See all LLY bonds
